Ron Gilat1, Omri Lubovsky, Ehud Atoun, Ronen Debi, Ornit Cohen, Yoram A Weil. 1. *Department of Orthopedic Surgery, Assaf Harofeh Medical Center, Zerifin, Israel;†Faculty of Health Sciences, Ben-Gurion University of the Negev, Department of Orthopedic Surgery, Barzilai Medical Center Campus, Ashkelon, Israel; and‡Department of Orthopedic Surgery, Hadassah Medical Center, Jerusalem, Israel.
Abstract
OBJECTIVE: To assess the incidence of proximal femoral shortening (PFS) and its effect on the patient outcomes when intertrochanteric fractures were treated with a cephalomedullary nail (CMN). DESIGN: Retrospective cohort study. SETTINGS: Level II trauma center. PATIENTS: Forty-eight consecutive patients with OTA/AO 31-A intertrochanteric fractures. INTERVENTION: All patients were treated with a Gamma3 CMN (Stryker, Kalamazoo, MI). METHODS: PFS was assessed for abductor lever arm (x vector), femoral height (y vector), and overall shortening (z vector) on anteroposterior radiographs. Fixation success and retained ambulatory capacity were noted. RESULTS: Shortening of >5 mm of the x, y, and z vectors was evident in 18, 20, and 29 patients, respectively. Shortening of >10 mm of the x, y, and z vectors was measured in 5, 6, and 8 patients, respectively. Mean shortening of the x, y, and z vectors was 4.5, 5.5, and 7 mm, respectively. Greater PFS was found to be associated with fixation failure and inability to retain ambulatory capacity, independently (P ≤ 0.05 and P ≤ 0.025, respectively). Of note, an unstable fracture pattern was not found to be associated with greater PFS. CONCLUSIONS: PFS is a common phenomenon after CMN of intertrochanteric fractures with a Gamma CMN. In addition, greater PFS seems to be associated with fixation failure and inability to retain ambulatory capacity postoperatively. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
OBJECTIVE: To assess the incidence of proximal femoral shortening (PFS) and its effect on the patient outcomes when intertrochanteric fractures were treated with a cephalomedullary nail (CMN). DESIGN: Retrospective cohort study. SETTINGS: Level II trauma center. PATIENTS: Forty-eight consecutive patients with OTA/AO 31-A intertrochanteric fractures. INTERVENTION: All patients were treated with a Gamma3 CMN (Stryker, Kalamazoo, MI). METHODS: PFS was assessed for abductor lever arm (x vector), femoral height (y vector), and overall shortening (z vector) on anteroposterior radiographs. Fixation success and retained ambulatory capacity were noted. RESULTS: Shortening of >5 mm of the x, y, and z vectors was evident in 18, 20, and 29 patients, respectively. Shortening of >10 mm of the x, y, and z vectors was measured in 5, 6, and 8 patients, respectively. Mean shortening of the x, y, and z vectors was 4.5, 5.5, and 7 mm, respectively. Greater PFS was found to be associated with fixation failure and inability to retain ambulatory capacity, independently (P ≤ 0.05 and P ≤ 0.025, respectively). Of note, an unstable fracture pattern was not found to be associated with greater PFS. CONCLUSIONS: PFS is a common phenomenon after CMN of intertrochanteric fractures with a Gamma CMN. In addition, greater PFS seems to be associated with fixation failure and inability to retain ambulatory capacity postoperatively. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.